Supplementary Tables: Economic burden in treated Japanese patients with relapsed/refractory large B-cell lymphoma.xlsx

Supplementary Table 1. Exchange rate and inflation rate conversion table. Supplementary Table 2. Additional baseline and treatment characteristics Supplementary Table 3. Distribution of patients by age group in each index regimen Supplementary Table 4. Median index dosage for each regimen Supplementary Table 5. Healthcare resource utilization during the follow-up period, by line of therapy and by index regimen. Supplementary Table 6. Age at SCT by age groups and line of therapy Supplementary Table 7. Adjusted direct nominal medical costs during the follow-up period, by line of therapy and by index regimen. Supplementary Table 8. Additional HCRU results for COVID-19 analysis.